Latest filing published 13 May 2014 for Pulmatrix, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gregory M. French: trading record in brief
Gregory M. French has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Sonoma Pharmaceuticals, Inc. and Pulmatrix, Inc. In total, 4 filings cover trades dated from 30 January 2007 to 11 May 2014.
Purchases make up the whole of the open-market record (3 purchases, €70k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant.
Half of the purchases are above €5,190 and half below.
On 13 May 2014 came the latest disclosure, a share grant in Pulmatrix, Inc. The last insider purchase was made public on 10 June 2010, 5,996 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gregory M. French
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 58,000 shares0Common StockSEC:0001144204-14-029993:0
- 3,020 shares@ US$1.99Common StockSEC:0001144204-10-032851:0Canonical exit: 8 Sept 2010 (T+90)
- 3,076 shares@ US$2.02Common StockSEC:0001144204-10-032736:0Canonical exit: 5 Sept 2010 (T+90)
- 10,000 shares@ US$7.81Common StockSEC:0001209191-07-006145:0Canonical exit: 30 Apr 2007 (T+90)
4 of 4 declarations
